港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

軒竹生物-B

30.120

+1.1203.86%

成交量：323.31萬

成交額：1.03億

市值：156.01億

市盈率：- -

高：33.960

開：28.000

低：28.000

收：29.000

52周最高：33.960

52周最低：23.820

股本：5.18億

香港流通股本：1.61億

量比：0.57

換手率：2.01%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：16.92

市盈率(LYR):- -

市銷率: 447.77

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

軒竹生物-B漲逾15%，較招股價漲超180%！公司擁超過十餘種正在研發的藥物管線

老虎资讯综合

多隻醫藥新股上市頭日收漲超100%！包括曾申報科創板IPO未果的新股

異動解讀 | 軒竹生物-B盤中大漲5.17%，新藥研發及商業化進展獲市場認可

異動解讀 | 軒竹生物-B上市次日大跌6.54%，或因獲利回吐及估值調整

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02575"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02575","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"軒竹生物-B","latestPrice":30.12,"timestamp":1760681176809,"preClose":29,"halted":0,"volume":3233127,"delay":0,"floatShares":160701996,"shares":517947790,"eps":0,"marketStatus":"交易中","change":1.12,"latestTime":"10-17 14:06:19","open":28,"high":33.96,"low":28,"amount":103286455,"amplitude":0.205517,"askPrice":30.28,"askSize":2000,"bidPrice":30.12,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1760688600000},"marketStatusCode":2,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":29,"openAndCloseTimeList":[[1760664600000,1760673600000],[1760677200000,1760688000000]],"volumeRatio":0.573785,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","floatShares":160701996,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.573785,"shares":517947790,"dividePrice":0,"high":33.96,"amplitude":0.205517,"preClose":29,"low":28,"week52Low":23.82,"pbRate":"16.92","psRate":"447.77","week52High":33.96,"institutionHeld":0,"latestPrice":30.12,"committee":-0.6,"eps":0,"divideRate":0,"volume":3233127,"delay":0,"ttmEps":0,"open":28,"prevYearClose":11.6,"prevWeekClose":11.6,"prevMonthClose":11.6,"prevQuarterClose":11.6,"fiveDayClose":11.6,"twentyDayClose":11.6,"sixtyDayClose":11.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02575\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02575\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02575\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02575\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02575","date":"2025-10-15","current":-22.444691,"percent":1,"low":-22.444691,"twenty":-22.444691,"median":-22.444691,"eighty":-22.444691,"high":-22.444691,"avg":-22.444691,"sd":0,"marketCap":13622026877},"quantilePoints":[{"date":"2025-10-15","current":-22.444691,"twenty":-22.444691,"median":-22.444691,"eighty":-22.444691,"marketCap":13622026877}],"updateTime":1760642413208},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02575\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1183774161","title":"軒竹生物-B漲逾15%，較招股價漲超180%！公司擁超過十餘種正在研發的藥物管線","url":"https://stock-news.laohu8.com/highlight/detail?id=1183774161","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183774161?lang=zh_tw&edition=fundamental","pubTime":"2025-10-17 10:29","pubTimestamp":1760668186,"startTime":"0","endTime":"0","summary":"10月17日，次新股$轩竹生物-B$盘中拉升逾15%，较招股价涨超180%！公开资料显示，轩竹生物是一家以创新为驱动的中国生物制药公司。截至最后实际可行日期，公司有超过十种药物资产在积极开发中，涵盖消化系统疾病、肿瘤和非酒精性脂肪性肝炎，包括三项NDA批准资产，一个药物项目处于NDA注册阶段，一个药物项目处于III期临床试验阶段，四个药物项目处于I期临床试验阶段，五个已获IND批准。轩竹生物此次全球发售所得款项净额约为7.01亿元。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"2575530714","title":"多隻醫藥新股上市頭日收漲超100%！包括曾申報科創板IPO未果的新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575530714","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575530714?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 16:58","pubTimestamp":1760605089,"startTime":"0","endTime":"0","summary":"银诺医药的暴涨更凸显了市场对核心创新资产的追捧。中国已成为全球第二大医药市场，其中创新药领域增长尤为迅猛。医药研发具有周期长、投入大、风险高的特点，一款新药从临床前研究到上市平均需投入 10 亿美元以上，成功率不足 10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02595","09939","BK1515","02575","00460","BK1574"],"gpt_icon":1},{"id":"1109943861","title":"異動解讀 | 軒竹生物-B盤中大漲5.17%，新藥研發及商業化進展獲市場認可","url":"https://stock-news.laohu8.com/highlight/detail?id=1109943861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109943861?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 15:00","pubTimestamp":1760598034,"startTime":"0","endTime":"0","summary":"10月16日，轩竹生物-B股价盘中大涨5.17%，延续了其上市以来的强劲表现。该公司于10月15日在港交所挂牌上市，上市首日即大涨126.72%，显示出投资者对这家创新生物制药公司的高度认可。尽管轩竹生物目前仍处于亏损阶段，但其商业化进程正在加速。市场普遍认为，随着公司产品线的不断丰富和商业化能力的提升，轩竹生物有望在未来实现快速增长。此次上市融资约7.01亿港元，将进一步支持公司的研发和商业化战略，为其长远发展奠定基础。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02575"],"gpt_icon":1},{"id":"1153186772","title":"異動解讀 | 軒竹生物-B上市次日大跌6.54%，或因獲利回吐及估值調整","url":"https://stock-news.laohu8.com/highlight/detail?id=1153186772","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153186772?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 09:34","pubTimestamp":1760578467,"startTime":"0","endTime":"0","summary":"港股新上市公司轩竹生物-B今日盘中大跌6.54%，引发市场关注。该公司昨日刚在港交所挂牌上市，首日表现强劲，收盘大涨126.72%。轩竹生物是一家创新驱动的生物制药公司，专注于消化系统疾病、肿瘤和非酒精性脂肪性肝炎等领域的药物研发。公司目前已有三款商业化产品，并拥有超过十种在研药物资产。尽管短期内股价出现波动，但投资者在关注该股时，需要同时考虑其创新能力、商业化进展以及整体行业环境等多重因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02575"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02575\",params:#limit:6,delay:false,,,undefined,":[]}}